Viridian Therapeutics, Inc. (VRDN)
30.18
+1.70
(+5.95%)
USD |
NASDAQ |
Nov 09, 16:00
30.18
0.00 (0.00%)
After-Hours: 17:58
Viridian Therapeutics Gross Profit (Annual) : 69.69M for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 69.69M |
| December 31, 2024 | -0.938M |
| December 31, 2023 | -1.008M |
| December 31, 2022 | 1.017M |
| December 31, 2021 | 2.343M |
| December 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| December 31, 2016 | 0.789M |
| December 31, 2015 | 0.066M |
| December 31, 2014 | 1.077M |
| December 31, 2013 | 1.818M |
| December 31, 2012 | 1.364M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Travere Therapeutics, Inc. | 419.65M |
| Vertex Pharmaceuticals, Inc. | 10.27B |
| TG Therapeutics, Inc. | 515.57M |
| ACADIA Pharmaceuticals, Inc. | 971.62M |
| Alnylam Pharmaceuticals, Inc. | 3.032B |